NYSE : STE
$4.24 (1.86%)
NYSE
Daniel A. Carestio
Medical - Specialties
Healthcare
STE
17937
IE
USD
0.29
2.09
1.54
0.38
0.31
$5.94B
3.82
3.17
23.32
9.92
$7.93
$785.1M
13.18%
17.64%
11.05%
7.29%
29.26
1.06
1.06
$270.00
$275.00
$269.00
4/5
13 Analysts
-13.84%
5.20
9/9
$1.25B
$10.74B
$3.54B
$1.1B
$23.91B
4.03
13.08
2.09
11.05%
8.47%
3.50%
4.37%
$114.75
100 days
| Name | Title |
|---|---|
| Cary L. Majors | Senior Vice President & President of Healthcare |
| Daniel A. Carestio | President, Chief Executive Officer & Director |
| Walter Rosebrough Jr. | Chief Executive Officer Emeritus & Senior Advisor |
| Karen L. Burton | Senior Vice President, Chief Financial Officer & Chief Accounting Officer |
| Mary Clare Fraser | SVP & Chief Human Resources Officer |
| Andrew Xilas | Senior Vice President & GM of Dental |
| Renato G. Tamaro | Vice President & Corporate Treasurer |
| Julie Winter | Vice President of Investor Relations & Corporate Communications |
| Lindsey McGowan | VP, Chief Compliance & Quality Officer |
| Kenneth E. Kohler | Senior Vice President & GM of AST |
| Julia K. Madsen | Senior Vice President & GM of Life Sciences |
| John Adam Zangerle | Senior Vice President, General Counsel & Secretary |
No votes yet today — be the first to share your view!
About STERIS plc (NYSE:STE) Stock
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope ... repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
STERIS Raises Dividend to $0.69 per share
2026-07-30 16:30:00
DUBLIN, IRELAND, July 30, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.69 per share. This represents a $0.06 increase in the dividend and the Company's 21st consecutive year of dividend growth. The dividend is payable on September 25, 2026, to shareholders of record at the close of business on September 4, 2026.
STERIS' Q1 Earnings on Deck: What's in Store for the Stock?
2026-07-28 10:46:16
STE is expected to deliver fiscal first-quarter revenue and EPS growth, driven by strength in Healthcare, continued momentum in AST, and healthy demand in Life Sciences.
STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026
2026-07-27 16:30:00
DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 first quarter results at 9:00 a.m. ET on August 6, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
Steris: A Good Moment To Buy Shares In This Sterilization Leader
2026-07-27 09:45:00
Steris provides infection prevention products and sterilization services to medical clientele (such as hospitals, outpatient surgery centers, and pharmaceutical companies). Steris has increased its dividend for 21 consecutive years. The 10-year dividend growth rate of 9.6% is strong, but more recent dividend raises have actually been over 10%. STE has a great financial position. Its long-term debt/equity ratio is 0.3, while the interest coverage ratio is over 18.
Entropy Technologies LP Has $2.19 Million Holdings in STERIS plc $STE
2026-07-27 04:04:04
Entropy Technologies LP lessened its position in shares of STERIS plc (NYSE: STE) by 25.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,899 shares of the medical equipment provider's stock after selling 3,398 shares during the period. Entropy Technologies LP's holdings
STERIS plc $STE Shares Acquired by Arrowstreet Capital Limited Partnership
2026-07-26 03:49:51
Arrowstreet Capital Limited Partnership boosted its stake in shares of STERIS plc (NYSE: STE) by 20.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 519,511 shares of the medical equipment provider's stock after purchasing an additional 88,872 shares during
Why Steris (STE) is a Top Growth Stock for the Long-Term
2026-06-22 10:46:08
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Steris (STE) Up 1% Since Last Earnings Report?
2026-06-10 12:31:04
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Frequently Asked Questions
What is the current STERIS plc (STE) stock price?
STERIS plc(NYSE:STE) stock price is $232.64 in the last trading session. During the trading session, STE stock reached the peak price of $269.44 while $195.14 was the lowest point it dropped to. The percentage change in STE stock occurred in the recent session was 1.86% while the dollar amount for the price change in STE stock was $4.24.
STE's industry and sector of operation?
The NYSE listed STE is part of Medical - Specialties industry that operates in the broader Healthcare sector.
Who are the executives of STE?
Cary L. Majors
| Senior Vice President & President of Healthcare
Daniel A. Carestio
| President, Chief Executive Officer & Director
Walter Rosebrough Jr.
| Chief Executive Officer Emeritus & Senior Advisor
Karen L. Burton
| Senior Vice President, Chief Financial Officer & Chief Accounting Officer
Mary Clare Fraser
| SVP & Chief Human Resources Officer
How many employees does STE have?
Number of STE employees currently stands at 17937. STE operates from 5960 Heisley Road, Dublin, DU 44060, IE.
Link for STE official website?
Official Website of STE is: https://www.steris.com
How do I contact STE?
STE could be contacted at phone #353 1 232 2000 and can also be accessed through its website. STE operates from 5960 Heisley Road, Dublin, DU 44060, IE.
How many shares of STE are traded daily?
The average number of STE shares traded daily for last 3 months was 822.08K.
What is the market cap of STE currently?
The market value of STE currently stands at $22.67B with its latest stock price at $232.64